Skip to main content
Premium Trial:

Request an Annual Quote

DNA Script: Patrick Eimerman, John Luckey

Patrick Eimerman has been named global head of marketing and John Luckey has been appointed as VP for product development at DNA Script. Both will be based at the company's new US office. Eimerman joins DNA Script from Illumina, where he held senior sales and marketing roles. Prior to that, he was director of sales at GenomOncology and worked at Roche NimbleGen and DNA2.0. He holds a PhD in microbiology and immunology from Stanford University and a BS in bacteriology from the University of Wisconsin-Madison. Luckey comes to DNA Script from Thrive Bioscience, where he was VP of engineering and manufacturing. Before that, he held development roles at RainDance Technologies, Pathogenetix, Roche NimbleGen, and OpGen. Luckey holds PhD and MBA degrees from the University of Wisconsin-Madison and a BS from Stanford University.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.